A Study of Inhaled GB002 for Treatment of WHO Group I Pulmonary Arterial Hypertension
Jacksonville, FL
The purpose of this study is to evaluate the safety, pharmacokinetics (PK), pharmacodynamics (PD), and biomarkers of inhaled GB002 in adults with World Health Organization (WHO) Group 1 Pulmonary Arterial Hypertension (PAH).